Also trades as: DMAQR (NASDAQ)
DMAQ NASDAQ
Deep Medicine Acquisition Corp.
1W: -68.4%
1M: -74.6%
3M: -74.6%
1Y: -71.3%
$2.96
Last traded 2024-01-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$12.9M
52W Range2.96-19.91
Volume73,881
Avg Volume132,219
Beta0.02
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHumphrey P. Polanen
Employees2
SectorFinancial Services
IndustryShell Companies
IPO Date2021-12-02
595 Madison Avenue
New York City, NY 10017
US
New York City, NY 10017
US
917 289 2776
About Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bright Vision Sponso | J-Other | 150,000 | — | 2023-10-31 |
| Chiang John | 0 | — | 2022-10-15 | |
| Chiang John | 0 | — | 2022-10-15 | |
| Bright Vision Sponso | J-Other | 406,500 | $10.00 | 2021-10-29 |
| LUO WEIXUAN | 0 | — | 2021-10-26 |